COVID-19 challenge for Industries


Pharmaceutical and biological engineers are also helping produce faster and cheaper diagnostic solutions, repurposing and developing new drugs to treat patients, isolating antibodies against the present coronavirus, and testing new vaccines. Janssen Research & Development and Moderna are accelerating the development of potential vaccines, while a team at the Wyss Institute is developing a surrogate non-COVID coronavirus for use in studies.



Meanwhile, services companies such as Ginkgo Bioworks and Twist Biosciences have offered their platform to help support technology development. And universities are putting research on hold and shifting their focus to COVID-19. In the upcoming May CEP, you can read an article that describes such work underway at Rensselaer Polytechnic Institute (RPI).


    COVID-19 challenge for Industries Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in